Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine | MicrobiomeTrials
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-09-24Est. Completion: 2029-05
Enrollment target: 3,000 participants
Locations
Hallym University Dongtan Sacred Heart Hospital /ID# 273581, Hwaseong, Gyeonggido, South Korea
Seoul National University Hospital /ID# 271892, Seoul, Seoul Teugbyeolsi, South Korea
Kangbuk Samsung Hospital /ID# 271893, Seoul, Seoul Teugbyeolsi, South Korea
Yonsei University Health System Severance Hospital /ID# 272639, Seoul, Seoul Teugbyeolsi, South Korea